Stock Track | REMEGEN Soars 8.40% as Hong Kong Biotech Stocks Rally

Stock Track

Oct 31

REMEGEN (09995) shares surged 8.40% in intraday trading, riding the wave of a broader rally in Hong Kong's biotech sector. The stock's impressive gain is part of a sector-wide uptrend, with several other biotech companies also posting significant increases.

REMEGEN, a leading biopharmaceutical company focusing on the discovery, development, and commercialization of innovative and differentiated biologic drugs, has been attracting investor attention amidst the sector rally. The company's strong performance today aligns with gains seen in other major biotech players in the Hong Kong market, including 3SBIO, which jumped 11%, and SKB BIO, which rose 7%.

While specific catalysts for today's biotech sector rally were not immediately clear, the widespread gains suggest a positive sentiment towards the industry. Factors such as advancements in drug development, favorable regulatory news, or increased interest in healthcare investments could be driving this uptick. Investors appear to be showing renewed confidence in the biotech sector, with REMEGEN benefiting from this broader market movement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1138975407"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1138975407\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1138975407?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-31 10:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138975407","market":"us","top_or_hot":-1,"title":"Stock Track | REMEGEN Soars 8.40% as Hong Kong Biotech Stocks Rally","media":"Stock Track","content":"<p>REMEGEN (09995) shares surged 8.40% in intraday trading, riding the wave of a broader rally in Hong Kong's biotech sector. The stock's impressive gain is part of a sector-wide uptrend, with several other biotech companies also posting significant increases.</p>\n\n<p>REMEGEN, a leading biopharmaceutical company focusing on the discovery, development, and commercialization of innovative and differentiated biologic drugs, has been attracting investor attention amidst the sector rally. The company's strong performance today aligns with gains seen in other major biotech players in the Hong Kong market, including 3SBIO, which jumped 11%, and SKB BIO, which rose 7%.</p>\n\n<p>While specific catalysts for today's biotech sector rally were not immediately clear, the widespread gains suggest a positive sentiment towards the industry. Factors such as advancements in drug development, favorable regulatory news, or increased interest in healthcare investments could be driving this uptick. Investors appear to be showing renewed confidence in the biotech sector, with REMEGEN benefiting from this broader market movement.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | REMEGEN Soars 8.40% as Hong Kong Biotech Stocks Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | REMEGEN Soars 8.40% as Hong Kong Biotech Stocks Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-31 10:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>REMEGEN (09995) shares surged 8.40% in intraday trading, riding the wave of a broader rally in Hong Kong's biotech sector. The stock's impressive gain is part of a sector-wide uptrend, with several other biotech companies also posting significant increases.</p>\n\n<p>REMEGEN, a leading biopharmaceutical company focusing on the discovery, development, and commercialization of innovative and differentiated biologic drugs, has been attracting investor attention amidst the sector rally. The company's strong performance today aligns with gains seen in other major biotech players in the Hong Kong market, including 3SBIO, which jumped 11%, and SKB BIO, which rose 7%.</p>\n\n<p>While specific catalysts for today's biotech sector rally were not immediately clear, the widespread gains suggest a positive sentiment towards the industry. Factors such as advancements in drug development, favorable regulatory news, or increased interest in healthcare investments could be driving this uptick. Investors appear to be showing renewed confidence in the biotech sector, with REMEGEN benefiting from this broader market movement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09995","symbol_name":"荣昌生物","start_time":0,"source_url":"","article_id":"1138975407","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138975407","pubTimestamp":1761879415,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"REMEGEN (09995) shares surged 8.40% in intraday trading, riding the wave of a broader rally in Hong Kong's biotech sector. The stock's impressive gain is part of a sector-wide uptrend, with several...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09995":"荣昌生物"},"translate_title":"个股追踪|REMEGEN飙升8.40%香港生物科技股反弹","themeId":"69a75b3810812074200ad6ccc4b69296","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09995":1},"content_text":"REMEGEN (09995) shares surged 8.40% in intraday trading, riding the wave of a broader rally in Hong Kong's biotech sector. The stock's impressive gain is part of a sector-wide uptrend, with several other biotech companies also posting significant increases.\nREMEGEN, a leading biopharmaceutical company focusing on the discovery, development, and commercialization of innovative and differentiated biologic drugs, has been attracting investor attention amidst the sector rally. The company's strong performance today aligns with gains seen in other major biotech players in the Hong Kong market, including 3SBIO, which jumped 11%, and SKB BIO, which rose 7%.\nWhile specific catalysts for today's biotech sector rally were not immediately clear, the widespread gains suggest a positive sentiment towards the industry. Factors such as advancements in drug development, favorable regulatory news, or increased interest in healthcare investments could be driving this uptick. Investors appear to be showing renewed confidence in the biotech sector, with REMEGEN benefiting from this broader market movement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}